Rigetti Computing Gets Closer To Crucial Quantum Milestone (Rating Upgrade)

Rigetti Computing has received an upgrade to Buy, primarily due to its significant progress toward developing a 100-qubit system with >99.5% fidelity, positioning it favorably for lucrative DARPA Stage B grants expected to enhance revenue. The company's valuation is deemed attractive, with a potential 33% upside to approximately $25 per share if book value multiples expand to historical averages, despite inherent risks associated with grant dependency.

Analysis

Rigetti Computing (RGTI) has received a 'Buy' rating upgrade, driven by significant advancements toward a critical quantum computing milestone: a 100-qubit system with over 99.5% fidelity. This technological progress is a key catalyst, as it positions the company favorably to secure lucrative Stage B grants from the Defense Advanced Research Projects Agency (DARPA), which would directly bolster its revenue stream. From a valuation perspective, the stock is presented as attractive, with a specified potential upside of 33% to a price target of approximately $25 per share. This target is, however, contingent on the company's book value multiples expanding to meet their historical averages. While the outlook is optimistic, supported by strong sector momentum, significant risks remain. The company's financial model is heavily reliant on grant funding, and successfully securing the DARPA Stage B candidacy is a critical, yet not guaranteed, future event.

Key Decisions for Investors

• Investors with a high-risk tolerance could consider the upgrade and specific technological catalysts as a basis for initiating a position, targeting the potential 33% upside to ~$25 per share.
• The primary factor to monitor is the company's progress in securing the DARPA Stage B grant, as this event is the central pillar of the near-term revenue growth thesis.
• Given that the investment case hinges on non-guaranteed grant awards and a reversion in valuation multiples, any position should be sized to reflect the speculative nature of the investment and the company's grant-dependent business model.
• Current holders may view the positive momentum and analyst upgrade as justification to maintain their position, while awaiting confirmation of the pivotal DARPA grant award.